Core Viewpoint - The article highlights the positive performance of the ChiNext Index and the photovoltaic sector, with significant growth in related ETFs and stocks, indicating a favorable investment environment in these areas [1][2][3]. Group 1: Market Performance - On September 17, the ChiNext Index experienced fluctuations but ultimately rose, with the photovoltaic sector showing active performance [1]. - The Tianhong ChiNext ETF (159977) increased by 1.6%, with a trading volume exceeding 181 million yuan, and notable stocks like Changying Precision surged over 11% [1]. - The photovoltaic ETF (159857) rose by 1.97%, with a trading volume surpassing 110 million yuan, and stocks such as TBEA and Luxshare Precision hitting the daily limit [1]. Group 2: Growth Projections - Tianhong Fund forecasts strong growth for the ChiNext Index, with expected revenue compound annual growth rate (CAGR) exceeding 20% and net profit CAGR surpassing 29% for 2025-2026 [2]. - The ChiNext Index is projected to outperform other broad indices like CSI 300 and CSI 500 in terms of revenue and profit growth [2]. Group 3: Macro and Valuation Insights - The macroeconomic environment is favorable, with overseas interest rate cuts and domestic monetary and fiscal easing, benefiting strategic emerging industries [3]. - The ChiNext Index is currently near its historical average valuation, with a price-to-earnings (PE) ratio of 41.87x, price-to-book (PB) ratio of 5.20x, and price-to-sales (PS) ratio of 4.33x, indicating potential for upward movement [3].

Group 1 - The robotics sector is experiencing significant activity, with the robotics ETF (159770) rising by 1.61% and achieving a trading volume exceeding 270 million yuan, marking it as the top performer in the Shenzhen market [1] - As of September 16, the latest circulating shares of the robotics ETF (159770) reached 7.554 billion, with a total market size of 8.442 billion yuan, setting a historical high and leading in the Shenzhen market [1] - Fourier Intelligence announced the pre-sale of its humanoid robot "Carebot" GR-3, which integrates 31 sensors for auditory, visual, and tactile interaction, set to officially launch in October [1] Group 2 - Shenzhen Huizhi IoT and Zhifang have formed a strategic partnership to deploy over 1,000 embodied intelligent robots in Huike's global production base over the next three years, with an order value close to 500 million yuan [2] - According to Wanlian Securities, China's industrial robot production is projected to reach 63,700 units by July 2025, a year-on-year increase of 24%, while service robot production is expected to reach 1,489,900 units, growing by 12.8% [2] - The Chinese robotics industry is anticipated to continue its growth trajectory, driven by recovering domestic and international demand, ongoing policy support, and improved product performance [2] Group 3 - Tianhong's CSI Robotics ETF (159770) tracks the CSI Robotics Index, which includes companies involved in system solutions, digital workshops, automation equipment manufacturing, and other robotics-related sectors [3] - The ETF covers key areas of the robotics industry chain, including core components, algorithm control modules, and motor battery modules [3] - Shanghai Securities highlights the imminent mass production of Optimus V3 and the deployment of the Miro robot in Midea's smart factory, indicating accelerated development in the humanoid robotics sector [3]

Group 1 - Tianhong Hengsheng Technology ETF (520923) will be launched from September 17, 2025, to September 23, 2025, with a maximum initial fundraising scale of 2 billion yuan [1] - The fund is managed by Tianhong Fund, with fund managers Hu Chao and Liu Dong [1] - The performance benchmark of the fund is the return rate of the Hang Seng Technology Index (adjusted for valuation exchange rates) [1]

Group 1 - The Hong Kong stock market is experiencing significant capital inflow, with Tianhong Fund announcing the establishment of the Tianhong Guozheng Hong Kong Stock Connect Technology Index Fund, raising over 2.5 billion yuan [1] - The fund manager highlighted three advantages of investing in Hong Kong's technology sector: scarcity of quality tech companies not covered by A-shares, valuation advantage with the index at around the 30th percentile over the past five years, and strong capital support from southbound funds [1][2] - Southbound funds have seen nearly 1 trillion Hong Kong dollars in net purchases this year, and expectations of interest rate cuts by the Federal Reserve may further improve liquidity in the Hong Kong market [1] Group 2 - The Tianhong Guozheng Hong Kong Stock Connect Technology Index Fund tracks 30 representative technology leaders across high-growth sectors such as the internet, electronics, communications, biotechnology, and smart vehicles, with a higher weight limit of 15% for constituent stocks [2]

Group 1 - The latest open-source model from Yushu Technology has reignited investment enthusiasm in the robotics sector, leading to a significant surge in related stocks and ETFs [1][2] - On September 16, the largest robotics ETF in the market saw a trading volume exceeding 2.5 billion yuan, reaching a new high since its inception, with multiple robotics-themed ETFs rising over 3% [1][4] - The release of the UnifoLM-WMA-0 model by Yushu Technology, designed for general robot learning, has showcased impressive capabilities, further driving market interest [2][6] Group 2 - The robotics sector has experienced two major waves of growth this year, with the first wave occurring from early January to late February, and the current wave being driven by technological advancements and market excitement [3][6] - The Huaxia Robotics ETF has seen a year-to-date increase of 12.747 billion shares, ranking it first among technology-themed ETFs in terms of growth [5][6] - Market sentiment is shifting towards companies with verified customer orders and production plans, indicating a trend towards performance-based investment strategies [6][7] Group 3 - The long-term market potential for humanoid robots is significant, with expectations of rapid growth supported by policy backing and funding [6][7] - Investment strategies are recommended to focus on leading supply chain companies with strong core competitiveness and stable cash flow, particularly those expanding into humanoid robotics [7]

Group 1 - Anhui Heli's stock increased by 5.01%, reaching 21.79 CNY per share, with a trading volume of 434 million CNY and a turnover rate of 2.28%, resulting in a total market capitalization of 19.408 billion CNY [1] - Anhui Heli Co., Ltd. is located in Hefei Economic and Technological Development Zone, established on September 30, 1993, and listed on October 9, 1996. The company specializes in the research, manufacturing, and sales of industrial vehicles, smart logistics, and key components, along with aftermarket services such as parts service, financing leasing, vehicle leasing, maintenance services, and remanufacturing [1] - The main business revenue composition includes 98.78% from forklifts and parts, and 1.22% from other supplementary services [1] Group 2 - Tianhong Fund holds a significant position in Anhui Heli, with its Tianhong CSI Engineering Machinery Theme Index Fund A (022069) reducing its holdings by 9,000 shares in the second quarter, now holding 26,100 shares, which accounts for 2.14% of the fund's net value, ranking as the tenth largest holding [2] - The Tianhong CSI Engineering Machinery Theme Index Fund A was established on October 29, 2024, with a latest scale of 6.9249 million CNY, achieving a year-to-date return of 22.63%, ranking 2240 out of 4222 in its category, and a cumulative return of 17.49% since inception [2]

Group 1 - The core viewpoint of the news highlights the performance and investment trends of the Tianhong Innovation Drug ETF (517380) and the Biopharmaceutical ETF (159859), indicating a positive inflow of funds into these ETFs [1][2] - As of September 15, the Tianhong Innovation Drug ETF (517380) has seen a net inflow of over 120 million yuan in the past six days, while the Biopharmaceutical ETF (159859) has attracted over 220 million yuan in the last five days [1][2] - The Tianhong Innovation Drug ETF (517380) is noted as the largest ETF in the market that spans the Shanghai, Shenzhen, and Hong Kong markets, tracking the Hang Seng Shanghai-Shenzhen-Hong Kong Innovation Drug Selected 50 Index, which covers both A-shares and Hong Kong stocks [1] Group 2 - The Biopharmaceutical ETF (159859) closely tracks the National Securities Biopharmaceutical Index, which selects the top 30 stocks in the biopharmaceutical sector based on market capitalization and liquidity, reflecting the overall performance of the biopharmaceutical industry [2] - According to CITIC Securities, the performance of sub-sectors such as innovative drugs, CXO, and biopharmaceuticals has shown recovery, indicating that China's pharmaceutical industry has gained global competitiveness [2] - CICC expresses optimism about the long-term development of the innovative drug industry, noting that domestic innovative drugs have transitioned from following trends to achieving FIC/BIC innovation, entering a new phase of qualitative improvement [2]

证券之星消息，9月16日发布《天弘庆享债券型发起式证券投资基金分红公告》。本次分红为2025年度 的第2次分红。公告显示，本次分红的收益分配基准日为9月9日，详细分红方案如下： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 本次分红对象为权益登记日在基金注册登记机构登记在册的本基金全体基金份额持有人。，权益登记日 为9月17日，现金红利发放日为9月18日。选择红利再投资方式的投资者，其红利按2025年09月17日除息 后的基金份额净值转换为基金份额，转换后的基金份额将于2025年09月18日直接计入其基金账户，2025 年09月19日起可以查询。根据相关法律法规规定，基金向投资者分配的基金收益，暂免征收所得税。本 基金本次分红免收分红手续费；选择红利再投资方式的投资者其红利再投资所得的基金份额免收申购费 用。 | 分级基金简称 | 代码 | 置准日置等净值 | 分红方案 | | | --- | --- | --- | --- | --- | | | | (元) | (元/10份) | | | 天弘庆享A | 010803 | 1. ...

Core Insights - The first batch of 10 Sci-Tech Bond ETFs raised a total of 30 billion CNY each in a single day, totaling 300 billion CNY, indicating strong market interest [1] - The second batch of Sci-Tech Bond ETFs also sold out in one day, raising approximately 400 billion CNY, continuing the trend of high demand [1] - The overall scale of Sci-Tech Bond ETFs has surpassed 1600 billion CNY, with the first batch alone exceeding 1230 billion CNY [3] Fund Details - The second batch includes 14 public funds, with 10 tracking the China Securities AAA Sci-Tech Innovation Company Bond Index, 3 tracking the Shanghai Securities AAA Sci-Tech Innovation Company Bond Index, and 1 tracking the Shenzhen Securities AAA Sci-Tech Innovation Company Bond Index [6][7] - The first batch of ETFs has shown significant growth, with individual fund sizes exceeding 100 billion CNY, and the Jia Shi Sci-Tech Bond ETF nearing 200 billion CNY, reflecting a growth of over 650% [3][4] Market Performance - The concentrated inflow of passive funds has led to a significant narrowing of excess yields by approximately 9 basis points within 1-2 months after the first batch's issuance [5] - The three indices have shown strong performance, with the China Securities AAA Sci-Tech Innovation Company Bond Index yielding 3.99% over the past three years, outperforming the overall bond index [8][10] Investment Outlook - The Sci-Tech Bond market is expected to continue expanding due to favorable policies, with the current stock of Sci-Tech Bonds accounting for 7% of the total credit bond market [10] - The flexibility and dual attributes of yield and liquidity of Sci-Tech Bond ETFs make them appealing to investors seeking stable returns [10]

来源：天弘基金 （原标题：天弘基金张戈：通信设备指数为何大幅回调又快速反弹？） ...